Eric McGinnis

VCH Clinical Title(s)

Hematopathologist

Research Focus

Blood, Heart and Circulation

Contact Info

eric.mcginnis@vch.ca

604-875-4111 ext.61096

EricMcGinnisHP

Biography

Dr. Eric McGinnis joined the Division of Hematopathology at Vancouver General Hospital in 2021 after completing residency training at the University of British Columbia (UBC). He is also a clinical assistant professor at UBC. His research interests include characterization of hematologic neoplasms by flow cytometry and cytogenomic methods and evaluation of novel methods for clinical implementation, in particular optical genome mapping.

News and Awards

Investigator Awards 2024 Recipients

Apr 9, 2024

Publications

American journal of clinical pathology -
Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
Martin SD, McGinnis E, Smith TW
International journal of laboratory hematology -
Evaluation of activated partial thromboplastin time coagulation waveform analysis for identification of patients with acquired factor VIII inhibitors.
McGinnis E, Wong SKW, Smith TW
American journal of clinical pathology -
Malaria Screening Using Front-Line Loop-Mediated Isothermal Amplification.
McGinnis E, Chan G, Hudoba M, Markin T, Yakimec J, Roland K
Cytometry. Part B, Clinical cytometry -
Clinical and laboratory features associated with myeloperoxidase expression in pediatric B-lymphoblastic leukemia.
McGinnis E, Yang D, Au N, Morrison D, Chipperfield KM, Setiadi AF, Liu L, Tsang A, Vercauteren SM
Transfusion -
Adaptations of transfusion systems to the COVID-19 pandemic in British Columbia, Canada: Early experiences of a large tertiary care center and survey of provincial activities.
McGinnis E, Guo RJ, Marcon KM, Berry B, Coupland R, Meneghetti V, Morrison D, Onell R, Steele L, Trudeau J, Wong M, Shih AW

Eric McGinnis

Biography

News and Awards

Investigator Awards 2024 Recipients

Publications

Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.

Evaluation of activated partial thromboplastin time coagulation waveform analysis for identification of patients with acquired factor VIII inhibitors.

Malaria Screening Using Front-Line Loop-Mediated Isothermal Amplification.

Clinical and laboratory features associated with myeloperoxidase expression in pediatric B-lymphoblastic leukemia.

Adaptations of transfusion systems to the COVID-19 pandemic in British Columbia, Canada: Early experiences of a large tertiary care center and survey of provincial activities.

Are you a researcher?